Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Electron. j. biotechnol ; 33: 29-35, May. 2018. tab, graf, ilus
Article in English | LILACS | ID: biblio-1022834

ABSTRACT

Background: P64k is a Neisseria meningitidis high molecular weight protein present in meningococcal vaccine preparations. The lpdA gene, which encodes for this protein, was cloned in Escherichia coli and the P64k recombinant protein was expressed in E. coli K12 GC366 cells under the control of a tryptophan promoter. P64k was expressed as an intracellular soluble protein about 28% of the total cellular protein. Several scale-up criteria of fermentation processes were studied to obtain the recombinant P64k protein at the pilot production scale. Results: The best operational conditions at a larger scale production of P64k recombinant protein were studied and compared using the four following criteria: Constant Reynold's number (Re constant), Constant impeller tip speed (n di constant), Constant power consumption per unit liquid volume (P/V constant) and Constant volumetric oxygen transfer coefficients (KLa/k constant). The highest production of the recombinant protein was achieved based on the constant KLa/k scale-up fermentation criterion, calculating the aeration rate (Q) and the impeller agitation speed (n) by iterative process, keeping constant the KLa/k value from bench scale. The P64k protein total production at the 50 l culture scale was 546 mg l -1 in comparison with the 284 mg l -1 obtained at 1.5 l bench scale. Conclusions: The methodology described herein, for the KLa/k scale-up fermentation criterion, allowed us to obtain the P64k protein at 50 l scale. A fermentation process for the production of P64k protein from N. meningitidis was established, a protein to be used in future vaccine formulations in humans.


Subject(s)
Bacterial Outer Membrane Proteins/biosynthesis , Recombinant Proteins/biosynthesis , Escherichia coli/metabolism , Neisseria meningitidis/metabolism , Tryptophan , Meningococcal Vaccines , Fermentation , Molecular Weight
2.
Journal of Veterinary Science ; : 99-101, 2012.
Article in English | WPRIM | ID: wpr-23570

ABSTRACT

A 21-kDa leptospiral lipoprotein (LipL21) was evaluated for its diagnostic potential to detect bovine leptospirosis by ELISA. Both native LipL21 (nLipL21) and recombinant LipL21 (rLipL21) proteins were tested and compared regarding diagnostic efficiency, and no statistically significant difference was observed. The sensitivity of rLipL21 ELISA for 62 microscopic agglutination test (MAT) positive sera was 100% and the specificity with 378 MAT negative sera was 97.09%. Thus, rLipL21 protein-based ELISA could be used as an alternative to MAT for the diagnosis of bovine leptospirosis.


Subject(s)
Animals , Cattle , Antibodies, Bacterial/blood , Antigens, Bacterial/biosynthesis , Bacterial Outer Membrane Proteins/biosynthesis , Cattle Diseases/blood , Enzyme-Linked Immunosorbent Assay/veterinary , Leptospira interrogans/isolation & purification , Leptospirosis/blood , Lipoproteins/biosynthesis , Recombinant Proteins/biosynthesis , Sensitivity and Specificity
3.
Rev. bras. parasitol. vet ; 18(2): 5-12, Apr.-June 2009. ilus, graf, tab
Article in Portuguese | LILACS | ID: lil-606771

ABSTRACT

No presente trabalho, um teste imunoenzimático por competição (cELISA) foi padronizado com a proteína recombinante de superfície rMSP5, clonada a partir do gene msp5 do isolado PR1 de A. marginale. O sequenciamento mostrou que o gene que codifica a rMSP5/PR1 tem 98 por cento de identidade com os isolados Flórida e Santa Maria, 97 por cento com isolados de Pernambuco, Brasil e Havana, Cuba e 91 por cento com A. centrale. O teste de cELISA-PR1 foi comparado com os testes de IFI e cELISA-USA. Para a padronização e validação do cELISA-PR1, foram utilizados 380 soros bovinos comprovadamente positivos ou negativos pelo cELISA-USA. Desse total, 245 soros positivos eram de animais de área endêmica e 135 soros eram negativos, de área livre de anaplasmose. Na padronização, foram utilizados 283 soros de bovinos, dos quais 135 eram negativos e 148 positivos. Os testes de cELISA-PR1 e IFI apresentaram especificidade de 100 e 99,3 por cento, sensibilidade de 100 e 98 por cento, com coeficiente kappa de 0,993 e 0,978, respectivamente. Na validação do teste, foram utilizados 245 soros de bovinos de áreas endêmicas para anaplasmose, testados pelo cELISA-PR1 e IFI e apresentaram especificidade de 96,7 e 69,1 por cento, sensibilidade de 98,9 e 96,3 por cento e coeficiente kappa de 0,956 e 0,699, respectivamente. Esses resultados permitem afirmar que o teste de cELISA-PR1 apresentou performance equivalente ao cELISA-USA, podendo também ser utilizado em estudos epidemiológicos, programas de controle e movimentação internacional de animais, enquanto a IFI, com os resultados menos precisos apresentados, não deve ser utilizada em situações que requerem maior rigor no diagnóstico.


A competitive enzyme-linked immunosorbent test using the PR1 recombinant major surface protein 5 (rMSP5-PR1-ELISA) of Anaplasma marginale was standardized and validated using sera from anaplasmosis free and endemic regions. The sequencing of the msp5 gene of PR1 isolate showed 98 percent of identity with the Florida and Saint Maries isolates, 97 percent with Brazil (Pernambuco) and Havana isolates; and 91 percent with A. centrale. The cELISA-PR1 test was compared to IFI and cELISA-USA. For the standardization and validation of the cELISA-PR1, 380 bovine sera were used, whereas 245 truly positives and 135 truly negatives sera tested by the cELISA-USA. In the standardization of the cELISA-PR1 135 negative and 148 positive bovine sera were used. The cELISA-PR1 and IFI tests showed 100 and 99.3 percent specificity, 100 and 98 percent, sensibility, and a kappa coefficient of 0.993 and 0.978, respectively. For test validation, 245 bovine sera from an anaplasmosis endemic area were analyzed by the cELISA-PR1 and IFI, which showed 96.7 and 69.1 percent specificity, 98.9 e 96.3 percent sensibility and kappa coefficient of 0.956 and 0.699, respectively. These results indicate that the cELISA-PR1, likewise the cELISA-USA, could sensitively and specifically detect cattle naturally infected with A. marginale and would be recommended for epidemiological studies, eradications program, and regulation of international cattle movement, while IFI, which presented lower specificity should not be used in situations that demand more specific diagnosis.


Subject(s)
Animals , Cattle , Anaplasma marginale , Bacterial Outer Membrane Proteins , Cloning, Molecular , Enzyme-Linked Immunosorbent Assay , Bacterial Outer Membrane Proteins/biosynthesis , Bacterial Outer Membrane Proteins/classification
4.
The Korean Journal of Internal Medicine ; : 94-99, 2002.
Article in English | WPRIM | ID: wpr-182207

ABSTRACT

BACKGROUND: Despite increasing importance of Acinetobacter baumannii in nosocomial infections and rapid development of multi-antimicrobial resistance in this strain, the resistance mechanisms of beta-lactam antimicrobials in A. baumannii were not clearly defined. In order to observe the resistance mechanisms against beta-lactams and carbapenem, we characterized the production of beta-lactamases and outermembrane protein (OMP) profiles for the 44 clinical isolates of A. baumannii. METHODS: The MICs of antimicrobials were determined by agar dilution test. The secondary beta-lactamases were characterized by isoelectric focusing, polymerase chain reactions and nucleotide sequencing, and the production of chromosomal beta-lactamases was quantitated by spectrophotometric method. For two strains with an elevated MIC of carbapenem, outermembrane protein (OMP) profile was analyzed by ultracentrifugation of the sonicated bacteral cells and SDS-PAGE. RESULTS AND CONCLUSION: Twenty two or 4 of 44 strains produced TEM-1-like beta-lactamase or PER-1 extended-spectrum beta-lactamase, respectively. However, when we analyzed the MICs of several beta-lactams with the beta-lactamase production, the resistance level of beta-lactam was mainly determined by the production of chromosomal beta-lactamase, not by the secondary beta-lactamases in the clinical isolates of A. baumannii. In two strains with an elevated MIC of imipenem, a decrease or loss of about 35 kDa and 22 kDa proteins in OMP was observed, which suggested that the change of OMP played a role in carbapenem resistance.


Subject(s)
Humans , Acinetobacter/drug effects , Acinetobacter Infections/drug therapy , Lactams/pharmacology , Bacterial Outer Membrane Proteins/biosynthesis , Carbapenems/pharmacology , Cross Infection/drug therapy , Drug Resistance, Bacterial , beta-Lactamases/biosynthesis
5.
Pakistan Journal of Pharmacology. 1992; 9 (2): 29-38
in English | IMEMR | ID: emr-26006

ABSTRACT

The outer membrane proteins [OMP] of four C. jejuni/coli isolates have been identified by SDS - PAGE using Sarkosyl extraction of crude membranes. Sarkosyl insoluble fractions of four strains consistently contained a major OMP in the range of 43 k to 48 k, in addition to some minor proteins. SDS - PAGE profile of animal - passed virulence enhanced strains, when compared with the original isogenic strains when compared with the original isogenic strains, revealed the presence of a protein band migrating at 66 k to 68 k in addition to the characteristic major OMP band, suggesting a selective enhancement of this protein during animal passage in presence of iron - dextran. This shift in OMP expression was associated with enhanced virulence of C. jejuni for BALB/c mice. Immunobloting to analyse the antigens in OMP showed antigenicity to the major OMP. The role of the 68 k OMP in the pathogenesis of C jejuni for BALB/c mice remains to be studied


Subject(s)
Bacterial Outer Membrane Proteins/biosynthesis , Iron , Mice
SELECTION OF CITATIONS
SEARCH DETAIL